Compare DNP & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNP | MMSI |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 1995 | 1996 |
| Metric | DNP | MMSI |
|---|---|---|
| Price | $10.54 | $68.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $100.38 |
| AVG Volume (30 Days) | 697.1K | ★ 709.8K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $5.76 |
| P/E Ratio | ★ N/A | $32.19 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $9.28 | $66.34 |
| 52 Week High | $10.65 | $99.26 |
| Indicator | DNP | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 63.22 | 39.87 |
| Support Level | $9.96 | $66.76 |
| Resistance Level | $10.65 | $71.57 |
| Average True Range (ATR) | 0.14 | 1.80 |
| MACD | 0.04 | 0.46 |
| Stochastic Oscillator | 86.87 | 34.62 |
DNP Select Income Fund Inc is a closed-ended investment management fund. Its investment objectives are current income and long-term growth of income, with capital appreciation as a secondary objective. The Fund seeks to achieve its investment objectives by investing mainly in a diversified portfolio of equity and fixed-income securities of companies in the public utilities industry. Under normal market conditions, more than 65% of the Fund's total assets are invested in securities of public utility companies engaged in the production, transmission, or distribution of electric energy, gas, or telephone services.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.